FDA OKs SANG's cyclosporine capsules

SANG and partner Abbott (ABT) received FDA marketing approval for Gengraf cyclosporin capsules, a bioequivalent to Novartis' Neoral cyclosporin capsules, to prevent organ rejection in kidney, liver an...